On September 2, 2021 Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, reported that the Company will participate in two upcoming virtual investor conferences (Press release, Fusion Pharmaceuticals, SEP 2, 2021, View Source [SID1234587205]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Morgan Stanley 19th Annual Global Healthcare Conference – The fireside chat will take place on Thursday, September 9, 2021 at 11:00am ET. Presenting on behalf of Fusion will be Chief Executive Officer John Valliant, Ph.D., and Chief Financial Officer John Crowley.

The H.C. Wainwright 23rd Annual Global Investment Conference – A recording of the presentation will be made available for on-demand viewing on Monday, September 13, at 7:00am ET. Presenting on behalf of Fusion will be Chief Executive Officer John Valliant, Ph.D.
Webcasts of each event will be available on the "Events and Presentations" page in the "Investors & Media" section of the Company’s website at View Source Replays of the webcasts will be archived on the Company’s website for 90 days following their respective presentation dates.